Arcadia Biosciences | 10-Q: Quarterly report
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights
Arcadia Biosciences | 10-K/A: Annual report (Amendment)
Arcadia Biosciences | 10-K: Annual report
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Schaefer Thomas J.
Arcadia Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals
Arcadia Biosciences: Q3 2023 Earnings Report
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights
Arcadia Biosciences | 10-Q: Q2 2023 Earnings Report
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Schaefer Thomas J.
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Carosella Deborah D
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Yoder Amy
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Bolles Albert D.
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director WALLER GREGORY D
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Murray Lilian Shackelford
No Data